Ascendis Pharma (spons. ADRs) Aktie Analyse
24.01.19 | Ascendis Pharma (spons. ADRs) Overweight | Cantor Fitzgerald | |
26.06.18 | Ascendis Pharma (spons. ADRs) Buy | Stifel, Nicolaus & Co., Inc. | |
26.09.16 | Ascendis Pharma (spons. ADRs) Outperform | Wedbush Morgan Securities Inc. |